Top Markets
#1 Trillions Trillions +4,371.22%
#2 Ozapay Ozapay +37.63%
#3 UnifAI Network UnifAI Network +26.77%
#4 Aria.AI Aria.AI +21.95%
#5 Zano Zano +17.34%
#6 Osaka Protocol Osaka Protocol +14.21%
#7 StakeStone StakeStone +13.94%
#8 Vestra DAO Vestra DAO +11.91%
#9 River Pts River Pts +10.84%
#10 pippin pippin +10.64%
Coin of the day
Trillions Trillions
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Classifica tra le azioni #99999
Acticor Biotech SAS operates as a clinical stage biotechnology company that... Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
Prezzo delle azioni
$0.28545656
Capitalizzazione di mercato
$4.50M
Variazione (1 giorno)
5.97%
Variazione (1 anno)
0.00%
Paese
FR
Scambia Acticor Biotech SAS (ALACT)

Categoria

Healthcare
Storico del prezzo dell'azione per Acticor Biotech SAS (ALACT)
Prezzo di chiusura più alto: $0.29 il 2024-12-01

Prezzo di chiusura più basso: $7.56 il 2021-11-01
Storico del prezzo dell'azione di Acticor Biotech SAS dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2024 -90.82%
2023 -58.62%
2022 31.92%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 $36.74 -53.49%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $451.49 -11.91%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $737.00 9.61%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $297.72 51.37%
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $94.95 -40.77%
AU